AMTYX
Price
$10.15
Change
+$0.02 (+0.20%)
Updated
Sep 5 closing price
Net Assets
688.39M
RWIFX
Price
$73.30
Change
+$0.34 (+0.47%)
Updated
Sep 5 closing price
Net Assets
137.57B
Interact to see
Advertisement

AMTYX vs RWIFX

Header iconAMTYX vs RWIFX Comparison
Open Charts AMTYX vs RWIFXBanner chart's image
AB All Market Real Return Advisor
Price$10.15
Change+$0.02 (+0.20%)
VolumeN/A
Net Assets688.39M
American Funds Capital World Gr&Inc R5
Price$73.30
Change+$0.34 (+0.47%)
VolumeN/A
Net Assets137.57B
AMTYX vs RWIFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AMTYX vs. RWIFX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMTYX is a Buy and RWIFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIFX has more cash in the bank: 138B vs. AMTYX (688M). AMTYX pays higher dividends than RWIFX: AMTYX (2.18) vs RWIFX (1.69). AMTYX was incepted earlier than RWIFX: AMTYX (16 years) vs RWIFX (23 years). AMTYX (1.01) is less costly to investors than RWIFX (0.46). AMTYX is a more actively managed with annual turnover of: 90.00 vs. RWIFX (27.00). AMTYX has a lower initial minimum investment than RWIFX: AMTYX (0) vs RWIFX (250). RWIFX (13.51) and AMTYX (13.33) have marching annual gain over last year. AMTYX return over 5 years is better than : 65.59 vs. RWIFX (48.74).
AMTYXRWIFXAMTYX / RWIFX
Total Expense Ratio0.970.46211%
Annual Report Gross Expense Ratio1.010.46220%
Fund Existence16 years23 years-
Gain YTD13.53516.42182%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets688M138B0%
Annual Yield % from dividends2.181.69129%
Returns for 1 year13.3313.5199%
Returns for 3 years23.8655.2743%
Returns for 5 years65.5948.74135%
Returns for 10 years80.9377.64104%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DSGN6.450.34
+5.56%
Design Therapeutics
RCT1.370.07
+5.38%
RedCloud Holdings PLC
GTLS199.450.09
+0.05%
Chart Industries
BEAGU10.65N/A
N/A
Bold Eagle Acquisition Corp
BCRX8.27N/A
N/A
BioCryst Pharmaceuticals